tag:blogger.com,1999:blog-8448663046375322498.post543640060737649412..comments2023-10-23T08:56:50.127-06:00Comments on Angry by Choice: Translational research, is it worth the hype?The Loraxhttp://www.blogger.com/profile/13361004494346338824noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-8448663046375322498.post-78185191709083656282008-03-23T04:18:00.000-06:002008-03-23T04:18:00.000-06:00The goal of Transitional research should not be th...The goal of Transitional research should not be the "prevent" a disease, rather to treat a disease. To a basic biomedical scientist this is a semantic, treating vs preventing. To a basic clinician grappling daily with the toll that the disease exacts on the lives of patients and left with inadequate products or just a library of vastly enlarged knowledge about the disease is woefully inadequate. There must be a group of clinical scientist acting like contact lenses to focus "select sections" of that vast information on to the symptomatic problems experienced in the disease. This effort is not "sexy" it is at the bottom of must every substantial therapeutic breakthrough. For each therapeutic breakthrough there was some clinician or clinician-surrogate practicing translational research. <BR/>Sir the goal can not be so obtuse and broad as "preventing" disease. This is a myopic opinion on the true work of translational research. Treatment of disease is the goal and the more acute and humble approach to the issue and for the patient suffering from the disease, this it the most meaningful approach. If along the way of focusing freshly generated bench-knowledge on the alleviation of disease symptoms, the Translational clinical-scientist discovers a means of preventing disease then great. But the goal is not prevention of disease, the goal of my translational research is to alleviate symptomatic suffering of the disease, by reversing the pathophysiology of the disease's symptomatic expression.<BR/><BR/>Ricky W. McCullough MD (BSc Biol, BA Chem, MSc Biol) and discoverer of the cure for IBS, irritable bowel syndrome via translational research; Mueller Medical LLC, 401-397-6203.Anonymousnoreply@blogger.com